These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 8619890)
21. Expression of non-adrenergic imidazoline sites in rat cerebral cortical astrocytes. Regunathan S; Feinstein DL; Reis DJ J Neurosci Res; 1993 Apr; 34(6):681-8. PubMed ID: 8315666 [TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of the specific imidazoline binding of [3H]idazoxan in the human cerebral cortex. Bricca G; Greney H; Dontenwill-Kieffer M; Zhang J; Belcourt A; Bousquet P Neurochem Int; 1993 Feb; 22(2):153-63. PubMed ID: 8439769 [TBL] [Abstract][Full Text] [Related]
23. Imidazoline binding sites on PC12 cells and bovine chromaffin cells. Steffen G; Dendorfer A; Dominiak P Ann N Y Acad Sci; 1995 Jul; 763():157-62. PubMed ID: 7677325 [TBL] [Abstract][Full Text] [Related]
24. [3H]cirazoline as a tool for the characterization of imidazoline sites. Angel I; Le Rouzic M; Pimoule C; Graham D; Arbilla S Ann N Y Acad Sci; 1995 Jul; 763():112-24. PubMed ID: 7677320 [TBL] [Abstract][Full Text] [Related]
25. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors. Olmos G; Kulkarni RN; Haque M; MacDermot J Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577 [TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of the imidazoline I2b-binding sites in the hamster brown adipose tissue as a study model for imidazoline receptors. Römer L; Wurster S; Savola JM; Raasmaja A Arch Physiol Biochem; 2003 Apr; 111(2):159-66. PubMed ID: 12919003 [TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of imidazoline binding sites revealed by a cirazoline derivative. Greney H; Molines A; Bousquet P; Dontenwill M Eur J Pharmacol; 1994 Dec; 271(2-3):533-6. PubMed ID: 7705454 [TBL] [Abstract][Full Text] [Related]
28. Identification of I1 and I2 imidazoline receptors in striatum membranes from different species. Vauquelin G; De Backer JP; Ladure P; Flamez A Ann N Y Acad Sci; 1999 Jun; 881():135-43. PubMed ID: 10415909 [TBL] [Abstract][Full Text] [Related]
29. Positive inotropic effects of imidazoline derivatives are not mediated via imidazoline binding sites but alpha1-adrenergic receptors. Raasch W; Chun KRJ ; Dendorfer A; Dominiak P Jpn J Pharmacol; 2000 Sep; 84(1):1-6. PubMed ID: 11043446 [TBL] [Abstract][Full Text] [Related]
30. [3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors. Lione LA; Nutt DJ; Hudson AL Eur J Pharmacol; 1996 May; 304(1-3):221-9. PubMed ID: 8813605 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo. Miralles A; Ribas C; Olmos G; García-Sevilla JA J Neurochem; 1993 Nov; 61(5):1602-10. PubMed ID: 8228980 [TBL] [Abstract][Full Text] [Related]
32. [3H]idazoxan binding to bovine adrenal medullary membranes: identification and pharmacological characterization of I2-imidazoline sites. Molderings GJ; Kundt L; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):252-7. PubMed ID: 7824041 [TBL] [Abstract][Full Text] [Related]
33. Imidazoline receptors in vascular smooth muscle and endothelial cells. Regunathan S; Youngson C; Wang H; Reis DJ Ann N Y Acad Sci; 1995 Jul; 763():580-90. PubMed ID: 7677378 [TBL] [Abstract][Full Text] [Related]
34. Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation. Regunathan S; Youngson C; Raasch W; Wang H; Reis DJ J Pharmacol Exp Ther; 1996 Mar; 276(3):1272-82. PubMed ID: 8786560 [TBL] [Abstract][Full Text] [Related]
35. Identification, localization and functional analysis of imidazoline and alpha adrenergic receptors in canine prostate. Felsen D; Ernsberger P; Sutaria PM; Nejat RJ; Nguyen P; May M; Breslin DS; Marion DN; Vaughan ED J Pharmacol Exp Ther; 1994 Feb; 268(2):1063-71. PubMed ID: 7509387 [TBL] [Abstract][Full Text] [Related]
36. The novel alpha 2-adrenoceptor agonist [3H]mivazerol binds to non-adrenergic binding sites in human striatum membranes that are distinct from imidazoline receptors. Flamez A; Gillard M; De Backer JP; Vauquelin G; Noyer M Neurochem Int; 1997 Jul; 31(1):125-9. PubMed ID: 9185172 [TBL] [Abstract][Full Text] [Related]
37. Down-regulation of imidazoline sites in rabbit kidney. Hamilton CA; Jardine E; Reid JL Eur J Pharmacol; 1993 Oct; 243(1):95-7. PubMed ID: 7902815 [TBL] [Abstract][Full Text] [Related]
38. Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney. Lachaud-Pettiti V; Podevin RA; Chrétien Y; Parini A Eur J Pharmacol; 1991 Jan; 206(1):23-31. PubMed ID: 1648494 [TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of imidazoline-binding sites from calf striatum. Czerwiec E; De Backer JP; Flamez A; Vauquelin G Eur J Pharmacol; 1996 Nov; 315(1):99-109. PubMed ID: 8960870 [TBL] [Abstract][Full Text] [Related]
40. Imidazoline/guanidinium binding sites and their relation to inhibition of K(ATP) channels in pancreatic B-cells. Rustenbeck I; Herrmann C; Ratzka P; Hasselblatt A Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):410-7. PubMed ID: 9303581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]